Precision for Medicine Re-approved as a CIR-Eligible R&D Partner Under the French Research Tax Credit Programme
|
FDA Veteran Paz Vellanki, MD, joins Precision to become one of 3 ex-FDA oncology leaders supporting clients
I recognize that relations between Sponsors and CRO vendors can be strained and difficult, often a blaming game; this has never been my experience with this group as it truly felt like a partnership.
At so many levels, the Precision for Medicine team has been fantastic. I am very grateful for how responsive and how collaborative the whole team is. Very grateful for their help.
Our partnership with Precision is a true textbook definition of a great collaboration between a sponsor and a CRO.
Precision for Medicine stands out for partnership and versatility. Everything has been completed on time, and we are looking forward to applying the lessons we learned here to future analysis endpoints.
Gain new insights and strategies from our experts at the forefront of clinical and translational research.
Discover
Embark on the critical first steps of clinical discovery with our expertly managed early phase trials, where meticulous attention meets innovative strategy
Discover the path to market with our Late Phase Development expertise – delivering precision, scale, and efficiency for your clinical journey.
Like you, we understand that there’s a patient throughout the development pathway. Supporting our partners to bring innovative treatments to patients is our purpose. Leverage our experience in these therapeutic areas.
Leverage an integrated infrastructure that reduces the inefficiencies inherent in complex development. Integrate lab and trial execution to accelerate speed to market. Precision can customize and converge our capabilities to meet your program's unique needs—driving efficiency, agility, and success from start to finish.
Award-winning CRO with deep oncology and rare disease expertise
Discover Explore
Exceptional translational and biomarker sciences with global central lab services